ARCELLX INC (ACLX) Fundamental Analysis & Valuation

NASDAQ:ACLX • US03940C1009

Current stock price

115.07 USD
+0.04 (+0.03%)
At close:
115.11 USD
+0.04 (+0.03%)
After Hours:

This ACLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ACLX Profitability Analysis

1.1 Basic Checks

  • In the past year ACLX has reported negative net income.
  • In the past year ACLX has reported a negative cash flow from operations.
  • ACLX had negative earnings in each of the past 5 years.
  • ACLX had negative operating cash flow in 4 of the past 5 years.
ACLX Yearly Net Income VS EBIT VS OCF VS FCFACLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • ACLX's Return On Assets of -37.90% is in line compared to the rest of the industry. ACLX outperforms 56.31% of its industry peers.
  • ACLX's Return On Equity of -56.90% is in line compared to the rest of the industry. ACLX outperforms 58.25% of its industry peers.
Industry RankSector Rank
ROA -37.9%
ROE -56.9%
ROIC N/A
ROA(3y)-20.52%
ROA(5y)-34.43%
ROE(3y)-31.69%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ACLX Yearly ROA, ROE, ROICACLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACLX Yearly Profit, Operating, Gross MarginsACLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ACLX Health Analysis

2.1 Basic Checks

  • ACLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ACLX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ACLX has been increased compared to 5 years ago.
  • There is no outstanding debt for ACLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACLX Yearly Shares OutstandingACLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ACLX Yearly Total Debt VS Total AssetsACLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 17.71 indicates that ACLX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ACLX (17.71) is better than 86.99% of its industry peers.
  • There is no outstanding debt for ACLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.71
ROIC/WACCN/A
WACC9.41%
ACLX Yearly LT Debt VS Equity VS FCFACLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • ACLX has a Current Ratio of 4.44. This indicates that ACLX is financially healthy and has no problem in meeting its short term obligations.
  • ACLX has a Current ratio of 4.44. This is comparable to the rest of the industry: ACLX outperforms 51.07% of its industry peers.
  • ACLX has a Quick Ratio of 4.44. This indicates that ACLX is financially healthy and has no problem in meeting its short term obligations.
  • ACLX has a Quick ratio (4.44) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.44
Quick Ratio 4.44
ACLX Yearly Current Assets VS Current LiabilitesACLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ACLX Growth Analysis

3.1 Past

  • ACLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.50%.
  • Looking at the last year, ACLX shows a very negative growth in Revenue. The Revenue has decreased by -79.35% in the last year.
EPS 1Y (TTM)-103.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.09%
Revenue 1Y (TTM)-79.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 29.30% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 99.45% on average over the next years. This is a very strong growth
EPS Next Y8.71%
EPS Next 2Y15.36%
EPS Next 3Y22.73%
EPS Next 5Y29.3%
Revenue Next Year186.52%
Revenue Next 2Y178.5%
Revenue Next 3Y136.48%
Revenue Next 5Y99.45%

3.3 Evolution

ACLX Yearly Revenue VS EstimatesACLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
ACLX Yearly EPS VS EstimatesACLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 -10

More info and screens

Find the best growth stocksShow best growing peers

1

4. ACLX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACLX. In the last year negative earnings were reported.
  • Also next year ACLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACLX Price Earnings VS Forward Price EarningsACLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACLX Per share dataACLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACLX's earnings are expected to grow with 22.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y22.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACLX Dividend Analysis

5.1 Amount

  • No dividends for ACLX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACLX Fundamentals: All Metrics, Ratios and Statistics

ARCELLX INC

NASDAQ:ACLX (4/27/2026, 8:00:00 PM)

After market: 115.11 +0.04 (+0.03%)

115.07

+0.04 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners87.47%
Inst Owner Change0.16%
Ins Owners1.37%
Ins Owner Change-1.61%
Market Cap6.73B
Revenue(TTM)22.29M
Net Income(TTM)-228.93M
Analysts55.65
Price Target113.36 (-1.49%)
Short Float %3.64%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)4.54%
Max EPS beat(2)8.44%
EPS beat(4)3
Avg EPS beat(4)-5.96%
Min EPS beat(4)-46.25%
Max EPS beat(4)9.43%
EPS beat(8)5
Avg EPS beat(8)-0.9%
EPS beat(12)6
Avg EPS beat(12)-6.33%
EPS beat(16)7
Avg EPS beat(16)-20.54%
Revenue beat(2)0
Avg Revenue beat(2)-70.13%
Min Revenue beat(2)-87.9%
Max Revenue beat(2)-52.37%
Revenue beat(4)0
Avg Revenue beat(4)-61.53%
Min Revenue beat(4)-87.9%
Max Revenue beat(4)-45.6%
Revenue beat(8)2
Avg Revenue beat(8)-25.59%
Revenue beat(12)3
Avg Revenue beat(12)-5.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)-1.09%
EPS NQ rev (1m)0.76%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)2.53%
EPS NY rev (3m)-5.01%
Revenue NQ rev (1m)-4.35%
Revenue NQ rev (3m)-8.88%
Revenue NY rev (1m)-11.08%
Revenue NY rev (3m)-28.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 301.95
P/FCF N/A
P/OCF N/A
P/B 16.72
P/tB 16.72
EV/EBITDA N/A
EPS(TTM)-4.07
EYN/A
EPS(NY)-3.72
Fwd EYN/A
FCF(TTM)-3.64
FCFYN/A
OCF(TTM)-3.6
OCFYN/A
SpS0.38
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -37.9%
ROE -56.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-20.52%
ROA(5y)-34.43%
ROE(3y)-31.69%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.85%
Cap/Sales 10.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.44
Quick Ratio 4.44
Altman-Z 17.71
F-Score2
WACC9.41%
ROIC/WACCN/A
Cap/Depr(3y)448.06%
Cap/Depr(5y)414.54%
Cap/Sales(3y)14.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.09%
EPS Next Y8.71%
EPS Next 2Y15.36%
EPS Next 3Y22.73%
EPS Next 5Y29.3%
Revenue 1Y (TTM)-79.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.17%
Revenue Next Year186.52%
Revenue Next 2Y178.5%
Revenue Next 3Y136.48%
Revenue Next 5Y99.45%
EBIT growth 1Y-83.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.9%
EBIT Next 3Y24.15%
EBIT Next 5Y27%
FCF growth 1Y-119.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.91%
OCF growth 3YN/A
OCF growth 5YN/A

ARCELLX INC / ACLX Fundamental Analysis FAQ

What is the fundamental rating for ACLX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACLX.


What is the valuation status for ACLX stock?

ChartMill assigns a valuation rating of 1 / 10 to ARCELLX INC (ACLX). This can be considered as Overvalued.


How profitable is ARCELLX INC (ACLX) stock?

ARCELLX INC (ACLX) has a profitability rating of 1 / 10.


What is the earnings growth outlook for ARCELLX INC?

The Earnings per Share (EPS) of ARCELLX INC (ACLX) is expected to grow by 8.71% in the next year.